Fennec Pharmaceuticals Inc. (FENC) stock
FENCNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/30196% above fair value
$11.62+0.72 (+6.61%)
Close on Nov 13, 2026Market cap $407.48MP/E 387.3Yield –
Fennec Pharmaceuticals statistics
76 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 8.28
- 2.22
- P/OCF Ratio
- 129.40
- 12.99
Enterprise valuationIndustry
- EV / Sales
- 5.41
- 2.57
- EV / EBIT
- 96.50
- 19.31
Share statisticsIndustry
- Shares Change (YoY)
- 30.5%
- 10.8%
- Shares Change (QoQ)
- 0.52%
- 0.50%
- Shares Held by Institutions
- 46.5%
- 56.4%
Short sellingIndustry
- Short Interest
- 454,453
- –
- Short Interest Change
- -6.78%
- -0.80%
- Short % of Shares Outstanding
- 1.30%
- 6.30%
- Days to Cover
- 3.89
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $13.25
- –
- 52-Week Low
- $5.65
- –
- 20-Day Moving Average
- $10.48
- –
- 50-Day Moving Average
- $10.64
- –
- 200-Day Moving Average
- $9.35
- –
- Average True Range (14)
- $0.74
- –
- Price Change (1 Week)
- 18.5%
- -1.15%
- Price Change (1 Month)
- 12.3%
- -4.87%
- Price Change (3 Months)
- -1.78%
- -21.0%
- Price Change (6 Months)
- 19.2%
- -20.6%
- Price Change (YTD)
- 50.9%
- -23.6%
- Price Change (1 Year)
- 49.4%
- -22.4%
- Price Change (3 Years)
- 43.5%
- -29.5%
- Price Change (5 Years)
- 21.9%
- -77.9%
- Price Change (10 Years)
- 606.9%
- -65.4%
- Average Volume (10 Days)
- 226,360
- –
- Average Volume (20 Days)
- 171,625
- –
- Average Volume (90 Days)
- 185,117
- –
- Relative Volume
- 2.55
- 0.70
- Relative Strength Index (14)
- 61.1
- 43.4
- Volatility (1 Year)
- 68.1%
- 80.1%
- Beta (5 Years)
- 0.82
- 1.07
MarginsIndustry
- EBITDA Margin
- 5.60%
- -27.7%
Returns on capitalIndustry
- Return on Equity (ROE)
- 9.07%
- -49.9%
- Return on Assets (ROA)
- 3.05%
- -40.6%
- Return on Capital Employed (ROCE)
- 5.29%
- -37.9%
Financial positionIndustry
- Current Ratio
- 6.11
- 3.30
- Quick Ratio
- 3.68
- 2.39
- Interest Coverage
- 11.66
- -6.35
GrowthIndustry
- Revenue Growth (YoY)
- 71.1%
- 6.82%
- Revenue Growth (3Y CAGR)
- 207.5%
- 2.25%
- Revenue Growth (5Y CAGR)
- 194.9%
- 6.41%
EfficiencyIndustry
- Asset Turnover
- 1.00
- 0.40
- Revenue Per Employee
- $1.90M
- $429.29K
- Profits Per Employee
- $57.91K
- -$689.41K
- Employee Count
- 35
- 74
- WACC
- 9.20%
- 10.2%
Income statement (TTM)Industry
Balance sheetIndustry
- Net Cash (Debt)
- $48.68M
- $17.76M
- Net Cash Per Share
- $1.39
- $0.80
- Equity (Book Value)
- $49.19M
- $53.89M
- Book Value Per Share
- $1.40
- $1.50
- Tangible Book Value
- $49.19M
- $27.13M
- Working Capital
- $67.71M
- $79.99M
Cash flow (TTM)Industry
Dividends and yieldsIndustry
- Earnings Yield
- 0.50%
- -21.8%
Taxes and interestIndustry
- Interest Expense
- $319.00K
- $2.90M
Scores and fair valueIndustry
- Graham Number
- $0.97
- $19.34
- Graham Upside
- -91.6%
- -46.6%
- Altman Z-Score
- 5.30
- 0.23
- Piotroski F-Score
- 1
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | FENC | S&P 500 | Difference | FENC per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +14.1% | -3.0% | +17.2 pts | ||
| 3 months | -3.6% | -2.8% | −0.9 pts | ||
| Year to date | +50.9% | +11.5% | +39.4 pts | ||
| 1 year | +51.1% | +13.5% | +37.6 pts | ||
| 3 years | +47.6% | +77.7% | −30.1 pts | +13.9% | +21.1% |
| 5 years | +21.9% | +72.6% | −50.7 pts | +4.0% | +11.5% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
0M FENC shares were sold short on Oct 30, 2026, down 6.8% from the previous report. At recent volumes it would take 3.9 days to buy them back. Over the last 20 sessions, 38.0% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 454,453 | -6.8% | 116,848 | 3.9 |
| Oct 15, 2026 | 487,514 | -5.0% | 129,085 | 3.8 |
| Sep 30, 2026 | 513,287 | -5.8% | 133,171 | 3.9 |
| Sep 15, 2026 | 545,039 | +4.7% | 258,376 | 2.1 |
| Aug 31, 2026 | 520,659 | -2.1% | 255,867 | 2.0 |
| Aug 14, 2026 | 532,095 | -13.6% | 245,478 | 2.2 |
| Jul 31, 2026 | 615,869 | +1.1% | 115,860 | 5.3 |
| Jul 15, 2026 | 609,189 | +24.6% | 182,924 | 3.3 |
| Jun 30, 2026 | 488,731 | +8.5% | 366,003 | 1.3 |
| Jun 15, 2026 | 450,578 | -9.5% | 224,711 | 2.0 |
| May 29, 2026 | 498,119 | -20.1% | 355,955 | 1.4 |
| May 15, 2026 | 623,377 | -41.2% | 386,241 | 1.6 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?